141 related articles for article (PubMed ID: 35993469)
1.
Li R; Cui X; Sun W; Yang Z; Shen X; Zhu C
Comb Chem High Throughput Screen; 2023; 26(7):1311-1323. PubMed ID: 35993469
[TBL] [Abstract][Full Text] [Related]
2. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
3. ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma.
Zhang S; Xu L; Feng J; Tan D; Zhu Y; Hou J; Li W; Lv K; Wang W; Jiang L; Jiao M; Guo H
Front Genet; 2022; 13():842351. PubMed ID: 35360875
[No Abstract] [Full Text] [Related]
4. ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma.
Ouyang X; Lv L; Zhao Y; Zhang F; Hu Q; Li Z; Zhu D; Li L
Front Oncol; 2021; 11():801506. PubMed ID: 35087760
[TBL] [Abstract][Full Text] [Related]
5. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma.
Qu LH; Fang Q; Yin T; Yi HM; Mei GB; Hong ZZ; Qiu XB; Zhou R; Dong HF
Cancer Immunol Immunother; 2022 Oct; 71(10):2449-2467. PubMed ID: 35254477
[TBL] [Abstract][Full Text] [Related]
7. Construction of Novel lncRNA-miRNA-mRNA Network Associated With Recurrence and Identification of Immune-Related Potential Regulatory Axis in Hepatocellular Carcinoma.
Zhan T; Gao X; Wang G; Li F; Shen J; Lu C; Xu L; Li Y; Zhang J
Front Oncol; 2021; 11():626663. PubMed ID: 34336642
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
9. RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma.
Peng H; Du X; Zhang Y
Front Mol Biosci; 2022; 9():898567. PubMed ID: 35720121
[No Abstract] [Full Text] [Related]
10.
Lu J; An SG; Ma JJ; Yang Y; Zhang L; Yu P; Tao H; Chen YF; Zhang HX
Chin Med Sci J; 2022 Dec; 37(4):331-339. PubMed ID: 36647592
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Prognostic Value, Immune Implication and Biological Function of
Huang Y; Huang S; Ma L; Wang Y; Wang X; Xiao L; Qin W; Li L; Yuan X
Front Immunol; 2021; 12():723293. PubMed ID: 34899687
[TBL] [Abstract][Full Text] [Related]
12. H2AFX might be a prognostic biomarker for hepatocellular carcinoma.
Hu H; Zhong T; Jiang S
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1684. PubMed ID: 35903980
[TBL] [Abstract][Full Text] [Related]
13. The interaction between
Zhang Z; Liu S
Ann Med; 2023 Dec; 55(1):1111-1122. PubMed ID: 36947060
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of prognostic value, relationship to cell cycle, immune infiltration and m6A modification of ZSCAN20 in hepatocellular carcinoma.
Jiayu F; Jiang Y; Zhou X; Zhou M; Pan J; Ke Y; Zhen J; Huang D; Jiang W
Aging (Albany NY); 2022 Dec; 14(23):9550-9578. PubMed ID: 36462500
[TBL] [Abstract][Full Text] [Related]
15. CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma.
Wang Z; Chen S; Wang G; Li S; Qin X
Biomed Res Int; 2021; 2021():6622437. PubMed ID: 33604380
[TBL] [Abstract][Full Text] [Related]
16. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
Tian F; Cai D
Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Pan-Cancer Analysis and the Regulatory Mechanism of ASF1B, a Gene Associated With Thyroid Cancer Prognosis in the Tumor Micro-Environment.
Ma J; Han W; Lu K
Front Oncol; 2021; 11():711756. PubMed ID: 34490109
[TBL] [Abstract][Full Text] [Related]
18. Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
Cui XH; Peng QJ; Li RZ; Lyu XJ; Zhu CF; Qin XH
J Cell Mol Med; 2021 Dec; 25(24):11097-11112. PubMed ID: 34741389
[TBL] [Abstract][Full Text] [Related]
19. SLC17A2 Expression Correlates with Prognosis and Immune Infiltrates in Hepatocellular Carcinoma.
Wang Z; Chen X; Jiang Z
Comb Chem High Throughput Screen; 2022; 25(12):2001-2015. PubMed ID: 35081886
[TBL] [Abstract][Full Text] [Related]
20. Prognostic biomarker MITD1 and its correlation with immune infiltrates in hepatocellular carcinoma (HCC).
Shen H; Wang Z; Ren S; Wang W; Duan L; Zhu D; Zhang C; Duan Y
Int Immunopharmacol; 2020 Apr; 81():106222. PubMed ID: 32007795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
